eli lilly tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Lilly's tirzepatide cuts diabetes risk,

This is a real-world adherence advantage that many patients find significant: No need to set a fasting alarm before taking your medication No planning around meals or morning routines No weekly injection preparation, sharps disposal, or storage requirements No refrigeration required for medication storage For women managing busy schedules like work, family, and caregiving, this kind of flexibility can meaningfully support long-term consistency with a treatment program

Morris AE, Schmid J

Furthermore, as of writing, in the Unites States, Medicaid which provides free or low-cost health coverage to low-income individuals is barred for providing access to GLP-1RA medications for weight loss alone (Pub

2018 Jan;77:18996